Insider Transactions in Q4 2020 at Phase Bio Pharmaceuticals Inc (PHAS)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 03
2020
|
Edmund Harrigan Director |
BUY
Open market or private purchase
|
Direct |
6,000
+50.0%
|
$24,000
$4.12 P/Share
|
|
Nov 24
2020
|
Clay Thorp Director |
BUY
Open market or private purchase
|
Direct |
2,000
+8.02%
|
$6,000
$3.5 P/Share
|
|
Nov 23
2020
|
Clay Thorp Director |
BUY
Open market or private purchase
|
Direct |
3,000
+12.53%
|
$9,000
$3.67 P/Share
|
|
Nov 23
2020
|
Glen Burkhardt SVP of Human Resources |
SELL
Open market or private sale
|
Direct |
3,497
-100.0%
|
$10,491
$3.45 P/Share
|
|
Nov 20
2020
|
Glen Burkhardt SVP of Human Resources |
BUY
Grant, award, or other acquisition
|
Direct |
3,497
+50.0%
|
$10,491
$3.0 P/Share
|
|
Nov 20
2020
|
Jonathan P Mow Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,643
+2.88%
|
$10,929
$3.0 P/Share
|
|
Nov 20
2020
|
Susan Elizabeth Arnold SVP, Technical Operations |
BUY
Grant, award, or other acquisition
|
Direct |
4,832
+21.18%
|
$14,496
$3.0 P/Share
|
|
Nov 20
2020
|
David James Ballance VP, Research and Sci. Affairs |
BUY
Grant, award, or other acquisition
|
Direct |
919
+9.74%
|
$2,757
$3.0 P/Share
|
|
Nov 20
2020
|
Michael York VP, Corporate Development |
BUY
Grant, award, or other acquisition
|
Direct |
2,662
+39.01%
|
$7,986
$3.0 P/Share
|
|
Nov 20
2020
|
Kristopher Hanson SVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
999
+50.0%
|
$2,997
$3.0 P/Share
|
|
Nov 20
2020
|
John P Sharp Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,305
+3.06%
|
$3,915
$3.0 P/Share
|
|
Nov 16
2020
|
Clay Thorp Director |
BUY
Other acquisition or disposition
|
Indirect |
10,586
+40.69%
|
-
|
|
Nov 16
2020
|
Clay Thorp Director |
BUY
Other acquisition or disposition
|
Direct |
2,144
+10.67%
|
-
|
|
Nov 16
2020
|
Clay Thorp Director |
SELL
Other acquisition or disposition
|
Indirect |
52,397
-100.0%
|
-
|
|
Oct 01
2020
|
Susan Elizabeth Arnold SVP, Technical Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
5,423
+29.2%
|
$5,423
$1.15 P/Share
|